Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holm Graessner

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
The Lancet. Global Health|June 14, 2024
Global health for rare diseases through primary careGareth Baynam, Adam L Hartman, Mary Catherine V Letinturier, et al.
European Journal of Human Genetics : EJHG|June 2, 2021
Solving patients with rare diseases through programmatic reanalysis of genome-phenome dataLeslie Matalonga, Carles Hernández-Ferrer, Davide Piscia, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
European Journal of Human Genetics : EJHG|August 16, 2021
Correction to: Solving patients with rare diseases through programmatic reanalysis of genome-phenome dataLeslie Matalonga, Carles Hernández-Ferrer, Davide Piscia, et al.
European Journal of Neurology|October 24, 2024
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)Casper Wittebrood, Marina Boban, Annchiara Cagnin, et al.
BMC Neurology|June 11, 2015
Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability studyJoaquim J Ferreira, Catarina Godinho, Ana T Santos, et al.
Lab Animal|June 24, 2024
Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe)Kornelia Ellwanger, Julie A Brill, Elke de Boer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 24, 2025
The burden of TTN variants in the genomic era: analysis of 18,462 individuals from the Solve-RD consortium and general recommendationsMaria Francesca Di Feo, Ida Paramonov, Leslie Matalonga Borrel, et al.
Orphanet Journal of Rare Diseases|April 25, 2023
Transition for adolescents with a rare disease: results of a nationwide German projectCorinna Grasemann, Jakob Höppner, Peter Burgard, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Rare Disease|May 29, 2025
From roadmap to a sustainable end-to-end individualized therapy pathwayAnneliene H Jonker, Elena-Alexandra Tataru, David P Dimmock, et al.
The Lancet. Global Health|June 14, 2024
Global health for rare diseases through primary careGareth Baynam, Adam L Hartman, Mary Catherine V Letinturier, et al.
European Journal of Human Genetics : EJHG|June 2, 2021
Solving patients with rare diseases through programmatic reanalysis of genome-phenome dataLeslie Matalonga, Carles Hernández-Ferrer, Davide Piscia, et al.
Nature Reviews. Drug Discovery|November 4, 2024
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmapAnneliene H Jonker, Elena-Alexandra Tataru, Holm Graessner, et al.
European Journal of Human Genetics : EJHG|August 16, 2021
Correction to: Solving patients with rare diseases through programmatic reanalysis of genome-phenome dataLeslie Matalonga, Carles Hernández-Ferrer, Davide Piscia, et al.
European Journal of Neurology|October 24, 2024
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)Casper Wittebrood, Marina Boban, Annchiara Cagnin, et al.
BMC Neurology|June 11, 2015
Quantitative home-based assessment of Parkinson's symptoms: the SENSE-PARK feasibility and usability studyJoaquim J Ferreira, Catarina Godinho, Ana T Santos, et al.
Lab Animal|June 24, 2024
Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe)Kornelia Ellwanger, Julie A Brill, Elke de Boer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 24, 2025
The burden of TTN variants in the genomic era: analysis of 18,462 individuals from the Solve-RD consortium and general recommendationsMaria Francesca Di Feo, Ida Paramonov, Leslie Matalonga Borrel, et al.
Orphanet Journal of Rare Diseases|April 25, 2023
Transition for adolescents with a rare disease: results of a nationwide German projectCorinna Grasemann, Jakob Höppner, Peter Burgard, et al.
Pageof 9